IDStewardship

JANUARY 13, 2025

In this article an infectious diseases pharmacist discusses five interesting things to know about sulopenem (Orlynvah). Authored by: Tina Zheng, Pharm.D., BCIDP UNDER CONSTRUCTION Article PostedXXX Sulopenem etzadroxil and probenecid (Orlynvah) was recently approved in October 2024 for the treatment of uncomplicated urinary tract infections (uUTI) caused by Escherichia coli , Klebsiella pneumoniae , or Proteus mirabilis.

Packaging 130

Packaging Labelling FDA 130

STAT

JANUARY 13, 2025

Johnson & Johnson said Monday it would buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of large drugmakers’ reentry into neuroscience and a sizable purchase that will provide a boost as the industry gathers for one of its largest events of the year. With the acquisition, the pharma giant will get Intra-Cellular’s Caplyta, which is approved to treat schizophrenia and bipolar-related depression.

131

131

European Pharmaceutical Review

JANUARY 13, 2025

GSK has agreed to acquire the biopharmaceutical firm IDRx Inc, a company focused on development of precision therapies for gastrointestinal stromal tumours (GIST). The deal is valued up to $1.15 billion, which includes an upfront payment of $1 billion. IDRx Inc could receive a further $150 million, subject to achievement of future regulatory approvals.

59

59

STAT

JANUARY 13, 2025

Health data company Truveta said Monday it’s partnering with health systems and drugmakers to launch the Truveta Genome Project , a database of genetic data that is expected to accelerate personalized medicine and help discover new drugs.  Truveta plans to use leftover biospecimens from patients — after they consent — receiving routine health care at participating health systems to create the database.

Medical Records 135

Medical Records Pharmaceutical Companies Pharmaceutical Companies Hospitals 135

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

OctariusRx

JANUARY 13, 2025

This week we are once again providing an update on the most recent drug shortages. Drug shortages are just below 100 different medications, with the Food and Drug Administration (FDA) noting 98 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.

Long-Term Care Facilities 88

Long-Term Care Facilities FDA 88

STAT

JANUARY 13, 2025

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that familiar routine of deadlines, online meetings, and the like has predictably returned. Of course, some folks have a more challenging re-entry if they are attending the J.P. Morgan Healthcare Conference, a sort of Woodstock for investors.

FDA 108

FDA 108

STAT

JANUARY 13, 2025

WASHINGTON — Former Trump administration health policy aide Abe Sutton is incoming President Trump’s likely pick to lead the Center for Medicare and Medicaid Innovation, two sources familiar with the plans told STAT.  Sutton would work under the surgeon and television personality Mehmet Oz as the administrator of the Centers for Medicare and Medicaid Services, if Oz is confirmed by the Senate.

88

88

Drug Topics

JANUARY 13, 2025

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.

281

281

STAT

JANUARY 13, 2025

SAN FRANCISCO — Cigna and Centene have bowed out of this year’s J.P. Morgan Healthcare Conference, a possible sign that leaders of large health care companies are looking to avoid public appearances in light of the assassination of a high-profile executive last month. The health insurance giants are among 11 major companies that dropped out of the industry’s main investor event, according to the final agenda posted by J.P.

Insurance 144

Insurance 144

Drug Topics

JANUARY 13, 2025

A conversation with Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JANUARY 13, 2025

LONDON — Seeking to build up its cancer business, GSK said Monday it is buying the privately held U.S. biotech IDRx for $1 billion upfront. The deal, which includes another $150 million in milestone payments, gives GSK an experimental treatment for a rare gastrointestinal cancer.  The announcement comes as much of the biopharma world gathers in San Francisco for the J.P.

128

128

Drug Topics

JANUARY 13, 2025

Sarah Gray, PharmD, GAICD, discussed her experience as a pharmacist who added nutrition counseling to her clinical expertise.

247

247

PharmaVoice

JANUARY 13, 2025

The first draft guidance provides an initial framework for how the agency will assess AI models in drug development, but the industry is still looking for more.

FDA 147

FDA 147

Drug Topics

JANUARY 13, 2025

Rite Aid recently released a survey detailing US patients perspective of how they engage with their pharmacists.

247

247

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmaVoice

JANUARY 13, 2025

Companies are looking to new countries like Vietnam for manufacturing needs, but change comes at a cost.

147

147

Drug Topics

JANUARY 13, 2025

A combination of ibuprofen and acetaminophen was found to be superior to hydrocodone and acetaminophen in managing pain after impacted mandibular third-molar extraction surgery.

247

247

Pharmacy Times

JANUARY 13, 2025

The new Medicare cap limits out-of-pocket drug costs to $2000 annually.

139

139

Fierce Healthcare

JANUARY 13, 2025

A recent confluence of events marks the first time in decades that there's been indication of real, meaningful change to the system, writes Blue Shield of California's Matthew Gibbs.

126

126

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JANUARY 13, 2025

If approved, nipocalimab can treat antibody positive individuals with generalized myasthenia gravis.

FDA 123

FDA 123

Pharmaceutical Technology

JANUARY 13, 2025

NVIDIA starts 2025 by announcing a trio of partnerships and a research collaboration to boost healthcare sector presence.

Mayo Clinic 110

Mayo Clinic 110

Fierce Healthcare

JANUARY 13, 2025

Though largely comprised of nurses, the walk-off that began Friday also includes physician associates and doctorsthe latter of which is a first for Oregon, per the Oregon Nurses Association.

108

108

pharmaphorum

JANUARY 13, 2025

GSK confirms that it has agreed to buy US biotech IDRx and its KIT inhibitor for rare gastrointestinal tumours for $1bn upfront.

103

103

Fierce Healthcare

JANUARY 13, 2025

The pending purchase values Access Healthcare at roughly $2 billion, per Bloomberg, and builds on the private equity firm's recent revenue cycle management dealmaking.

108

108

PhRMA

JANUARY 13, 2025

The three largest Pharmacy Benefit Managers (PBMs) continue to abuse the health care system, significantly marking up a wide range of lifesaving medicines according to a new report from the Federal Trade Commission (FTC).

100

100

The Checkup by Singlecare

JANUARY 13, 2025

A compounded medication is a custom formulation of an existing brand-name or generic drug made by a licensed pharmacist and designed to meet a patients unique needs. For example, a person who is allergic to a common dye included in a prescription drug could have a compounded version of the drug made without that dye. More notably, compounded drugs are also made to counteract drug shortages.

Compounding 98

Compounding Compounding Pharmacies FDA Insurance Coverage 98

pharmaphorum

JANUARY 13, 2025

Metsera is leaving no fundraising stone unturned as it races to grab a slice of the fast-growing market for obesity drugs, cueing up an IPO.

98

98

The Checkup by Singlecare

JANUARY 13, 2025

If you or someone you know experiences weight-related challenges or Type 2 diabetes, medications like Zepbound and Mounjaro might be part of the conversation when it comes to treatment options. These medications both involve a weekly injection and share the same active ingredient, tirzepatide. As a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide can help control appetite and decrease sugar levels.

Insurance 92

Insurance Dosage Insurance Coverage FDA 92

pharmaphorum

JANUARY 13, 2025

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project.

96

96

Pharmacy Times

JANUARY 13, 2025

Managing comorbidities, ensuring proper dosing, and treating IVIG-related adverse events are areas where pharmacists play a large role.

91

91

Fierce Healthcare

JANUARY 13, 2025

SCAN Group will make a strategic investment in Cresta, which has built a generative AI platform for contact centers, the insurer told Fierce Healthcare exclusively.

Insurance 88

Insurance 88

pharmaphorum

JANUARY 13, 2025

Discover how data science and AI are set to revolutionise the life sciences industry by 2025, with a focus on mRNA technology and CRISPR gene editing. Stay ahead of the curve with these cutting-edge advancements.

85

85

Fierce Healthcare

JANUARY 13, 2025

The two companies will co-develop and deploy integrated AI-driven products that address needs across predictive and personalized care, interoperability, efficiency, diagnostics and patient engagement.

86

86

Pharmacy Times

JANUARY 13, 2025

Pharmacy Times interviews Jennifer Clements, a clinical professor and the director of pharmacy education at the University of South Carolina, about glucagon-like peptide-1 receptors for diabetes treatment.

81

81